WCM
LKFT

Weld Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Weld Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,313
Closed -$328K – 544
2020
Q3 		$328K Buy
+2,313
New +$386K 0.13% 268
2019
Q3 		– Sell
-5,386
Closed -$694K – 849
2019
Q2 		$694K Buy
+5,386
New +$639K 0.13% 277

Other funds holding LKFT

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Weld Capital Management's LKFT Position: Q4 2020 in Review

Weld Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2020, closing a stake of 2,313 shares — an estimated $328K sold.

Weld Capital Management first reported a position in LKFT in Q2 2019 and held it in 2 quarters. The position peaked at $694K in Q2 2019. 116 funds tracked by Wall St. Rank hold LKFT as of Q4 2020.

  • Weld Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Weld Capital Management sold 2,313 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2020, an estimated $328K.
  • Weld Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2019 and held it in 2 quarters.
  • Weld Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $694K in Q2 2019.
  • 116 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2020.

Based on Weld Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.